Matthew M. Poppe
( out of 38 reviews )

Matthew M. Poppe, MD, FASTRO

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112
801-581-2396
Get Directions

Matthew Poppe, MD, a Huntsman Cancer Institute (HCI) physician and investigator, is a professor in the Department of Radiation Oncology at the University of Utah. He is a member of the multidisciplinary pediatric, sarcoma, and breast teams and is director of the residency program in Radiation Oncology.

As the primary radiation oncologist providing radiation for kids with cancer, he is actively engaged in Children’s Oncology Group and conducts translational, clinical, and outcomes research. He works with the COG in the design of new pediatric clinical trials and is currently the radiation co-chair of AALL 1732, A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy.

Dr. Poppe is actively engaged in the research and the care of patients with breast cancer. He currently serves as co-chair of the Breast Local Control group and Vice Chair for the Breast Committee for the Alliance Cooperative Trials Group and is a member of the NCI BOLD Task Force for the Breast Cancer Steering Committee. He is the principal investigator on an international trial (RT CHARM/Alliance A221505), which is a phase III randomized trial evaluating the safety and efficacy of short course radiation in the setting of mastectomy with breast reconstruction. He is also the principal investigator of a phase II trial at Huntsman Cancer Institute, evaluating a novel 9-day hypofractionated course of whole breast radiation. Additionally, he has published 34 peer-reviewed manuscripts, 3 book chapters, and presented numerous posters at national and international meetings. In 2018, he was recognized as a Huntsman Translational Scholar.

Dr. Poppe earned a bachelor’s degree in mechanical engineering at Santa Clara University, Santa Clara, CA. He worked in engineering at NASA AMES before attending medical school at Oregon Health Sciences University, Portland, OR. Dr. Poppe completed a Family Practice residency through the University of California Davis, Mercy Medical Center, Redding, California. In 2001, Dr. Poppe entered active duty in the US Air Force and practiced family and aerospace medicine until 2006. Dr. Poppe completed his radiation oncology residency at the Rutgers Cancer Institute of New Jersey. During residency, he was active in residency training issues as a review committee member for the Accreditation Council for Graduate Medical Education and Executive member of the Association of Residents in Radiation Oncology.

Specialties

Patient Rating

Patients consistently describe Dr. Poppe as knowledgeable, professional, and compassionate with a polite, humble demeanor. Reviewers report that he listens carefully, explains diagnoses and treatment options clearly, includes patients in decision-making, and follows up to ensure questions are answered. Many also note his team's professionalism and that visits feel thorough, unhurried, and reassuring.

Generated via Patient Reviews

4.9 /5
( out of 38 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

HUNTSMAN CANCER CENTER

I had many questions about participating in a phase 1 clinical trial and all my concerns were addressed adequately.

HUNTSMAN CANCER CENTER

Good

HUNTSMAN CANCER CENTER

Dr. Poppie and his staff are smart and made me have absolute confidence in the care that I will receive.

HUNTSMAN CANCER CENTER

He was so compassionate and helpful when I'd ask questions. His kind and loving demeanor really helped me feel comfortable through this process.

HUNTSMAN CANCER CENTER

He is very calming, great communication.

HUNTSMAN CANCER CENTER

I felt that he did not read my health. history before my appointment and I drove 4 hours to see him.

HUNTSMAN CANCER CENTER

Very personable and professional.

HUNTSMAN CANCER CENTER

I felt the level of care was exceptional. They always asked about my comfort, explained things clearly, even had Spotify while I was waiting for results. This was for a radiation planning session, CT scan

HUNTSMAN CANCER CENTER

I requested this meeting prior to surgery due to a family experience with breast cancer. Spencer (student), Teresa (PA), and Matt Poppe (doctor) all provided important information and clear explanations; Dr. Poppe gave me advice and recommendations when I requested them.

HUNTSMAN CANCER CENTER

took time to explain what they where going to do and talk about my cancer. answered all questions.

HUNTSMAN CANCER CENTER

Dr. Poppe is so smart and know about his practice. I highly recommend him and completely trust that he will make the best decisions for my treatment.

HUNTSMAN CANCER CENTER

Dr. Poppe was kind and explained my situation and what I should expect moving forward with my care.

HUNTSMAN CANCER CENTER

Dr. Poppe is an excellent doctor. As a patient I feel taken care of! I feel so grateful to have a skilled and personal doctor I can totally trust!

HUNTSMAN CANCER CENTER

We love Dr. Poppe. He has taken good care of my son and treats him with dignity and respect.

SUGAR HOUSE HEALTH CENTER

Dr. Poppe was caring and listened to my concerns. He answered questions that others should have already answered for me.

HUNTSMAN CANCER CENTER

I had to fight my insurance company to be able to continue with Dr. Poppe. I did not want to have someone else take over my care plan. He saved my life.

HUNTSMAN CANCER CENTER

Both Dr. Poppe and his fellow were wonderful. They gave very thorough explanations, were very candid and really put my mind at ease. I felt very comfortable being in their care.

HUNTSMAN CANCER CENTER

Dr. Poppe is very friendly and professional. Answered all of my questions and addressed my concerns.

HUNTSMAN CANCER CENTER

Dr Poppe is easy to talk to, to present questions to and he's professional and kind. He actually looks me in the eye when he chats with me. He also isn't offended when I ask questions about radiation treatment options. Dr Poppe is the one I would refer my own daughter or son to for cancer treatment if the need ever arose.

HUNTSMAN CANCER CENTER

Dr. Poppe recognized me as an individual, and worked with me as a collaborator regarding my treatment. He earned my trust, and I highly recommend his care.

HUNTSMAN CANCER CENTER

Dr Poppe is one the kindest and most understanding Doctors I've had the pleasure of being treated by! He listened to all of my concerns and questions that both me and my husband asked. If I ever need radiation, he will be the one that I go too.

HUNTSMAN CANCER CENTER

Dr Poppe was very kind, patient and knowledgeable. He is creative and thinks outside the box. He solved a setup problem with my first modeling visit today.

HUNTSMAN CANCER CENTER

Dr Poppe is knowledgeable, humble and a gentleman. He takes time to explained your treatment and follow up with you every week to see how you are doing. You feel that your is only patient because he sit down and gives you is full attention. He is the best you can find!

HUNTSMAN CANCER CENTER

emailed with me afterwards to make sure my questions were answered to the best of his ability. went above and beyond!

HUNTSMAN CANCER CENTER

Visit felt comprehensive and not rushed.

HUNTSMAN CANCER CENTER

Dr poppe actually called me this morning to go over our plan again. He wanted to changed somethings and I appreciate that that he called me to talk before he changed them

HUNTSMAN CANCER CENTER

Very kind man, and doctor

HUNTSMAN CANCER CENTER

He's very professional, clear and knowledgeable. He also makes sure I understand what is going on. I would highly recommend him to anyone I know.

SUGAR HOUSE HEALTH CENTER

Very kind

HUNTSMAN CANCER CENTER

Very kind and respectful. Answered all my questions in a kind way

HUNTSMAN CANCER CENTER

I recommend Dr. Poppe to anyone with cancer! He's awesome.

HUNTSMAN CANCER CENTER

very nice very professional at ease with all the information was open to my questions and included me in all decisions

HUNTSMAN CANCER CENTER

Dr Poppe really listens and always answers our questions thoroughly.

HUNTSMAN CANCER CENTER

very thoughtful and thorough

HUNTSMAN CANCER CENTER

I was happy to have Dr Poppe once again but I was not considered in my health care

HUNTSMAN CANCER CENTER

He is very polite and caring. He is very concerned about my health and answer all my questions respectfully!

HUNTSMAN CANCER CENTER

I love Dr. Poppe.

HUNTSMAN CANCER CENTER

A knowledgeable professional with impeccable manners , humble and a great passion for the health of his patients.

HUNTSMAN CANCER CENTER

Dr. Poppe is first rate in every way. He is caring, thoughtful, professional, knowledgeable, and personable.

HUNTSMAN CANCER CENTER

Muy buen doctor. Muy amable y contestó todas mis preguntas

HUNTSMAN CANCER CENTER

Dr. Poppe and his entire team were professional, compassionate, and provided clear information.

HUNTSMAN CANCER CENTER

Excellent Doctor, very professional and very kind. [TRANSLATED]

HUNTSMAN CANCER CENTER

Dr Poppe is excellent

HUNTSMAN CANCER CENTER

Very kind and explains everything

HUNTSMAN CANCER CENTER

Dr. Poppe is very aware of things going on and makes sure I know what is going on.

HUNTSMAN CANCER CENTER

Excellent

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Matthew Poppe, MD, a Huntsman Cancer Institute (HCI) physician and investigator, is a professor in the Department of Radiation Oncology at the University of Utah. He is a member of the multidisciplinary pediatric, sarcoma, and breast teams and is director of the residency program in Radiation Oncology.

As the primary radiation oncologist providing radiation for kids with cancer, he is actively engaged in Children’s Oncology Group and conducts translational, clinical, and outcomes research. He works with the COG in the design of new pediatric clinical trials and is currently the radiation co-chair of AALL 1732, A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy.

Dr. Poppe is actively engaged in the research and the care of patients with breast cancer. He currently serves as co-chair of the Breast Local Control group and Vice Chair for the Breast Committee for the Alliance Cooperative Trials Group and is a member of the NCI BOLD Task Force for the Breast Cancer Steering Committee. He is the principal investigator on an international trial (RT CHARM/Alliance A221505), which is a phase III randomized trial evaluating the safety and efficacy of short course radiation in the setting of mastectomy with breast reconstruction. He is also the principal investigator of a phase II trial at Huntsman Cancer Institute, evaluating a novel 9-day hypofractionated course of whole breast radiation. Additionally, he has published 34 peer-reviewed manuscripts, 3 book chapters, and presented numerous posters at national and international meetings. In 2018, he was recognized as a Huntsman Translational Scholar.

Dr. Poppe earned a bachelor’s degree in mechanical engineering at Santa Clara University, Santa Clara, CA. He worked in engineering at NASA AMES before attending medical school at Oregon Health Sciences University, Portland, OR. Dr. Poppe completed a Family Practice residency through the University of California Davis, Mercy Medical Center, Redding, California. In 2001, Dr. Poppe entered active duty in the US Air Force and practiced family and aerospace medicine until 2006. Dr. Poppe completed his radiation oncology residency at the Rutgers Cancer Institute of New Jersey. During residency, he was active in residency training issues as a review committee member for the Accreditation Council for Graduate Medical Education and Executive member of the Association of Residents in Radiation Oncology.

Board Certification and Academic Information

Academic Departments Radiation Oncology -Professor (Clinical)

Education history

Undergraduate Mechanical Engineering - Santa Clara University B.S.
Professional Medical Medicine - Oregon Health Sciences University M.D.
Residency Family Practice - University of California Davis/Mercy Medical Center Resident
Residency Radiation Oncology - Robert Wood Johnson Hospital/UMDNJ Resident

Selected Publications

Journal Article

  1. Cruttenden J, Grant J, Evans J, Cannon G, Gaffney DK, Poppe M, Burt LM, Avizonis V, Boothe (2025). Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer. American journal of clinical oncology, 48(5), 222-229.
  2. Poppe MM, Boucher K, Gaffney DK, Brownson KE, Smith G, Howell JN, Ticona FF, Kim J, Burt L, Cannon D, Kokeny (2025). NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer. International journal of radiation oncology, biology, physics, 123(1), 141-149.
  3. Potter S, Avery K, Ahmed R, de Boniface J, Chatterjee S, Dodwell D, Dubsky P, Federmann J, Finestone S, Gnant M, Hlauschek D, Iwata H, Jiang MY, Kaidar-Person O, Lee HB, MacKenzie M, Meyn A, Poortmans P, Poulakaki F, Richardson AL, Sepulveda KA, Spillane AJ, Thompson AM, Werutsky G, Wittmann P, Wright JL, Zdenkowski N, Cowan K, McIntosh SA, PRECEDENT Study Grou (2025). A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials. NPJ breast cancer, 11(1), 116.
  4. Zhao H, Sarkar V, St James S, Paxton A, Su FF, Price RG, Dial C, Poppe M, Gaffney D, Salter (2024). Verification of surface-guided radiation therapy (SGRT) alignment for proton breast and chest wall patients by comparison to CT-on-rails and kV-2D alignment. Journal of applied clinical medical physics, 25(2), e14263.
  5. Howell J, Maughan B, Fluchel M, Poppe (2024). Pediatric regimens in the treatment of adult-onset, metastatic Wilms tumor: A case report. Urology case reports, 56, 102799.
  6. Rose ML, Moen E, Ager B, Bajaj B, Poppe M, Russo G, Yock T (2024). Radiotherapy dosing in intracranial ependymoma using the national cancer database. Journal of neuro-oncology,
  7. Poppe MM, Tai A, Li XA, Miften M, Olch A, Marks LB, Qureshi BM, Spunt SL, Shnorhavorian M, Nelson G, Ronckers C, Kalapurakal J, Marples B, Constine LS, Liu A (2024). Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International journal of radiation oncology, biology, physics, 119(2), 560-574.
  8. Shaitelman SF, Anderson BM, Arthur DW, Bazan JG, Bellon JR, Bradfield L, Coles CE, Gerber NK, Kathpal M, Kim L, Laronga C, Meattini I, Nichols EM, Pierce LJ, Poppe MM, Spears PA, Vinayak S, Whelan T, Lyons J (2024). Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Practical radiation oncology, 14(2), 112-132.
  9. Yashar C, Khan AJ, Chen P, Einck J, Poppe M, Li L, Yehia ZA, Vicini FA, Moore D, Arthur D, Quinn TJ, Kowzun M, Simon L, Scanderbeg D, Shah C, Haffty BG, Kuske (2023). Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial. Practical radiation oncology, 13(4), 314-320.
  10. Berrington de González A, Gibson TM, Lee C, Albert PS, Griffin KT, Kitahara CM, Liu D, Mille MM, Shin J, Bajaj BVM, Flood TE, Gallotto SL, Paganetti H, Ahmed SK, Eaton BR, Indelicato DJ, Milgrom SA, Palmer JD, Baliga S, Poppe MM, Tsang DS, Wong K, Yock T (2023). The Pediatric Proton and Photon Therapy Comparison Cohort: Study Design for a Multicenter Retrospective Cohort to Investigate Subsequent Cancers After Pediatric Radiation Therapy. Advances in radiation oncology, 8(6), 101273.
  11. Weil CR, Lew FH, Williams VM, Burt LM, Ermoian RP, Poppe M (2022). Patterns of Care and Utilization Disparities in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. Advances in radiation oncology, 7(6), 100868.
  12. Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer, 128(19), 3564-3572.
  13. Peterson JS, Peckham ME, Poppe MM, Burt LS, Shrieve DC, Cannon D (2022). Delineating the Subarachnoid Space in the Adult Lumbosacral Spine Using Computed Tomographic Myelography: An Aid for Clinical Target Volume Delineation in Craniospinal Irradiation. Advances in radiation oncology, 7(5), 100994.
  14. von Mehren M, Kane JM, Riedel RF, Sicklick JK, Pollack SM, Agulnik M, Bui MM, Carr-Ascher J, Choy E, Connelly M, Dry S, Ganjoo KN, Gonzalez RJ, Holder A, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Mesko NW, Meyer C, Pappo AS, Parkes AM, Petersen IA, Poppe M, Schuetze S, Shabason J, Spraker MB, Zimel M, Bergman MA, Sundar H, Hang L (2022). NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022. Journal of the National Comprehensive Cancer Network, 20(11), 1204-1214.
  15. Parsons MW, Whipple NS, Poppe MM, Mendez JS, Cannon DM, Burt L (2021). The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma. Journal of neuro-oncology, 151(2), 93-101.
  16. Weiss A, Campbell J, Ballman KV, Sikov WM, Carey LA, Hwang ES, Poppe MM, Partridge AH, Ollila DW, Golshan (2021). Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Annals of surgical oncology, 28(11), 5960-5971.
  17. Lucas CG, Villanueva-Meyer JE, Whipple N, Oberheim Bush NA, Cooney T, Chang S, McDermott M, Berger M, Cham E, Sun PP, Putnam A, Zhou H, Bollo R, Cheshier S, Poppe MM, Fung KM, Sung S, Glenn C, Fan X, Bannykh S, Hu J, Danielpour M, Li R, Alva E, Johnston J, Van Ziffle J, Onodera C, Devine P, Grenert JP, Lee JC, Pekmezci M, Tihan T, Bollen AW, Perry A, Solomon DA (2020). Myxoid Glioneuronal Tumor, PDGFRA p.K385-mutant: Clinical, Radiologic, and Histopathologic Features. Brain pathology (Zurich, Switzerland), 30(3), 479-494.
  18. von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Homsi J, Keedy V, Kelly CM, Kim E, Liebner D, McCarter M, McGarry SV, Meyer C, Pappo AS, Parkes AM, Paz IB, Petersen IA, Poppe M, Riedel RF, Rubin B, Schuetze S, Shabason J, Sicklick JK, Spraker MB, Zimel M, Bergman MA, George G (2020). NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. Journal of the National Comprehensive Cancer Network, 18(12), 1604-1612.
  19. Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ, Lloyd S, Kokeny KE, Hitchcock YJ, Poppe MM, Gaffney DK, Tao (2020). Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer medicine, 9(21), 7954-7963.
  20. Poppe MM, Yehia ZA, Baker C, Goyal S, Toppmeyer D, Kirstein L, Chen C, Moore DF, Haffty BG, Khan A (2020). 5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial. International journal of radiation oncology, biology, physics, 107(4), 694-700.
  21. Khan AJ, Chen PY, Yashar C, Poppe MM, Li L, Abou Yehia Z, Vicini FA, Moore D, Dale R, Arthur D, Shah C, Haffty BG, Kuske R (2019). Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial. . International journal of radiation oncology, biology, physics, 104(1), 67-74.
  22. Wells S, Ager B, Hitchcock YJ, Poppe M (2019). The radiation dose-response of non-retroperitoneal soft tissue sarcoma with positive margins: An NCDB analysis. Journal of surgical oncology, 120(8), 1476-1485.
  23. Boothe D, Orton A, Kim J, Poppe MM, Werner TL, Gaffney D (2019). Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?. American journal of clinical oncology, 42(11), 813-817.
  24. Ager BJ, Christensen MT, Burt LM, Poppe M (2019). The value of high-dose radiotherapy in intracranial ependymoma. Pediatric blood & cancer, 66(6), e27697.
  25. Zhao H, Williams N, Poppe M, Sarkar V, Wang B, Rassiah-Szegedi P, Huang YJ, Kokeny K, Gaffney D, Salter (2019). Comparison of surface guidance and target matching for image-guided accelerated partial breast irradiation (APBI). Medical physics, 46(11), 4717-4724.
  26. Frandsen JE, Cannon G, Kokeny KE, Gaffney DK, Matsen C, Wright M, Poppe M (2018). Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. The breast journal, 24(1), 7-11.
  27. Tward JD, Poppe MM, Hitchcock YJ, O'Neil B, Albertson DJ, Shrieve D (2018). Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas. Cancer medicine, 7(12), 6030-6039.
  28. Huang YJ, Su FF, Gaffney DK, Kokeny KE, Zhao H, Rassiah-Szegedi P, Salter BJ, Poppe M (2018). Skin dose estimation using virtual structures for Contura Multi-Lumen Balloon breast brachytherapy. Brachytherapy, 17(6), 956-965.
  29. Torgeson A, Boothe D, Poppe MM, Suneja G, Gaffney D (2017). Disparities in care for elderly women with endometrial cancer adversely effects survival. Gynecologic oncology, 147(2), 320-328.
  30. Odei B, Frandsen JE, Boothe D, Ermoian RP, Poppe M (2017). Patterns of Care in Proton Radiation Therapy for Pediatric Central Nervous System Malignancies. International journal of radiation oncology, biology, physics, 97(1), 60-63.
  31. Bingham B, Orton A, Boothe D, Stoddard G, Huang YJ, Gaffney DK, Poppe M (2017). Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement. International journal of radiation oncology, biology, physics, 97(5), 1040-1050.
  32. Khan AJ, Poppe MM, Goyal S, Kokeny KE, Kearney T, Kirstein L, Toppmeyer D, Moore DF, Chen C, Gaffney DK, Haffty B (2017). Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. Journal of clinical oncology, 35(18), 2037-2043.
  33. Boothe D, Williams N, Odei B, Poppe MM, Werner TL, Suneja G, Gaffney D (2017). The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care. International journal of gynecological cancer, 27(5), 912-922.
  34. Frandsen J, Cannon G, Kokeny KE, Gaffney DK, Wright M, Pena K, Poppe M (2017). Post-mastectomy Radiotherapy for pT3N0 Breast Cancers: A Retrospective, Multi-Institution Review. The breast journal, 23(4), 452-455.
  35. Francis SR, Frandsen J, Kokeny KE, Gaffney DK, Poppe M (2017). Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers. Breast (Edinburgh, Scotland), 32, 156-161.
  36. Burt LM, Ying J, Poppe MM, Suneja G, Gaffney D (2017). Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results. Breast (Edinburgh, Scotland), 35, 122-129.
  37. Ahmed F, Sarkar V, Gaffney DK, Salter B, Poppe M (2016). Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes. Medical dosimetry, 41(3), 195-8.
  38. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, Werner TL, Gaffney D (2016). Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival. Gynecologic oncology, 141(3), 421-427.
  39. Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, L Werner T, Gaffney D (2016). Corrigendum to "Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival" [Gynecol. Oncol. 141 (2016) 421-427]. Gynecologic oncology, 143(3), 690-691.
  40. Burt L, Poppe MM, Kokeny KE, Gaffney DK, Shrieve DC, Tward J (2016). Comparison of treatment modalities for breast cancer arising in Hodgkin's lymphoma survivors. Journal of radiation oncology,
  41. Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney (2016). Brachytherapy improves survival in primary vaginal cancer. Gynecologic oncology, 141(3), 501-506.
  42. Mazur MD, Ravindra VM, Alashari M, Raetz E, Poppe MM, Bollo R (2015). Primary T cell central nervous system lymphoblastic lymphoma in a child: case report and literature review. Child's nervous system, 31(6), 977-84.
  43. Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe M (2015). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. International journal of radiation oncology, biology, physics, 93(5), 1096-103.
  44. Frandsen JE, Wagner A, Bollo RJ, Shrieve DC, Poppe M (2015). Long-term life expectancy for children with ependymoma and medulloblastoma. Pediatric blood & cancer, 62(11), 1986-91.
  45. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Tsien C, Winter JN, Yahalom J, Burns JL, Sundar H, National comprehensive cancer network (2015). Hodgkin Lymphoma, Version 2.2015. Journal of the National Comprehensive Cancer Network, 13(5), 554-586.
  46. Badiyan SN, Shah C, Arthur D, Khan AJ, Freedman G, Poppe MM, Vicini F (2014). Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies. Radiotherapy and oncology, 110(1), 39-44.
  47. Gondi V, Bernard JR Jr, Jabbari S, Keam J, de Amorim Bernstein KL, Dad LK, Li L, Poppe MM, Strauss JB, Chollet CT, ARRO Executive Committee. (2012). Results of the 2005 to 2008 Association of Residents in Radiation Oncology surveys of chief residents in the United States: didactics and research experience. Am J Clin Oncol, 35(1), 32-9.
  48. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H (2012). Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network, 10(5), 589-97.
  49. Tunceroglu A, Park JH, Balasubramanian S, Poppe M, Anker CJ, Poplin E, Moss RA, Yue NJ, Carpizo D, Gannon CJ, Haffty BG, Jabbour S (2012). Dose-Painted Intensity Modulated Radiation Therapy Improves Local Control for Locally Advanced Pancreas Cancer. ISRN oncology, 2012, 572342.
  50. Poppe MM, Narra V, Yue NJ, Zhou J, Nelson C, Jabbour S (2011). A comparison of helical intensity-modulated radiotherapy, intensity-modulated radiotherapy, and 3D-conformal radiation therapy for pancreatic cancer. Medical dosimetry, 36(4), 351-7.
  51. Gondi V, Bernard JR Jr, Jabbari S, Keam J, de Amorim Bernstein KL, Dad LK, Li L, Poppe MM, Strauss JB, Chollet CT, ARRO Executive Committee (2011). Results of the 2005-2008 Association of Residents in Radiation Oncology survey of chief residents in the United States: clinical training and resident working conditions. International journal of radiation oncology, biology, physics, 81(4), 1120-7.
  52. Yovino S, Poppe M, Jabbour S, David V, Garofalo M, Pandya N, Alexander R, Hanna N, Regine W (2011). Intensity-Modulated Radiation Therapy (IMRT) Significantly Improves Acute Gastrointestinal Toxicity in Pancreatic and Ampullary Cancers. International journal of radiation oncology, biology, physics, 79(1), 158-162.
  53. Zhao H, Wang B, Rassiah-Szegedi P, Huang Y, Sarkar V, Szegedi M, Sadinski M , Kokeny K, Poppe M, Salter (2011). SU-E-T-527: Comparison of CT-On-Rails and a 3D Surface Imaging System for Image Guided Partial Breast Radiation Therapy. Medical physics, 38(6), 3610.
  54. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom (2011). Hodgkin Lymphoma. Journal of the National Comprehensive Cancer Network, 9(9), 1020-58.

Review

  1. Chang JH, Poppe MM, Hua CH, Marcus KJ, Esiashvili (2021). Acute lymphoblastic leukemia. Pediatric blood & cancer, 68 Suppl 2, e28371.
  2. Aridgides P, Janssens GO, Braunstein S, Campbell S, Poppe M, Murphy E, MacDonald S, Ladra M, Alapetite C, Haas-Kogan (2021). Gliomas, germ cell tumors, and craniopharyngioma. Pediatric blood & cancer, 68 Suppl 2, e28401.
  3. Poppe MM, Agarwal J (2017). Breast Reconstruction With Postmastectomy Radiation: Choices and Tradeoffs. Journal of clinical oncology, 35(22), 2467-2470.

Book Chapter

  1. Poppe MM, Jalali R, Murphy (2018). Pediatric Glioma. 171-202.
  2. Poppe MM, Shah, C, Khan, (2016). Hypofractionated Regional Nodal Irradiation for Breast Cancer. 441-466.
  3. Poppe MM, Blodgett T (2012). Kidney.
  4. Poppe MM, Gaffney D (2012). Adrenal Gland.

Letter

  1. Poppe MM, Khan A (2021). In Reply to Dyer et al. International journal of radiation oncology, biology, physics, 109(1), 301-302.
  2. Meyer JE, Dilling TJ, Amdur RJ, Strasser JF, Tendulkar R, Lee WR, Jani AB, Elshaikh M, Poppe MM, Takita C, Currey A, Cheng SK, Jagsi R, Kuo JV, Chen AM, Dragun AE, Bradley K, Beriwal S, Smith RP, Chen RC, Rosenzweig K, Kim S, Mehta (2016). In regard to Wu and Vapiwala et al. International journal of radiation oncology, biology, physics, 94(4), 858-9.
  3. Meyer JE, Dilling TJ, Amdur RJ, Strasser JF, Tendulkar R, Lee WR, Jani AB, Elshaikh M, Poppe MM, Takita C, Currey A, Cheng SK, Jagsi R, Kuo JV, Chen AM, Dragun AE, Bradley K, Beriwal S, Smith RP, Chen RC, Rosenzweig K, Kim S, Mehta (2016). In regard to Wu and Vapiwala et al., Taking “the Game” Out of The Match: A Simple Proposal. International journal of radiation oncology, biology, physics, 94(5), 858-9.

Abstract

  1. Bagshaw H, Poppe MM, Hunter (2016). Recurrent Medulloblastoma and Radiotherapy. International journal of radiation oncology, biology, physics, 96(S2), 553.

News & Podcasts

Huntsman Cancer Institute News